Satellos Bioscience Stock Quote MSCL - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.60

Bid

0.60

Ask

0.62

Volume

43,500

0.56 Day's Range 0.60

0.45 52 Week Range 1.32

Market Cap

99.492M

Previous Close

0.58

Open

0.59

Last Trade

5000

0.6

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

169,636

Shares Outstanding

165,820,000

Dividend Yield

PE Ratio

-3.54

Earnings Per Share (EPS)

-0.17

Revenue

Net Profit

-28.1M

Sector

Coml Physical, Biologcl Resh

Industry

Pharmaceutical Preparations

Website

www.satellos.com

Headquarters

Toronto, Ontario, Can

Founded

2007

Satellos Bioscience Inc is listed in the Coml Physical, Biologcl Resh sector of the Toronto Stock Exchange with ticker MSCL. The last closing price for Satellos Bioscience was $0.58. Over the last year, Satellos Bioscience shares have traded in a share price range of $ 0.45 to $ 1.32.

Satellos Bioscience currently has 165,820,000 shares outstanding. The market capitalization of Satellos Bioscience is $96.18 million. Satellos Bioscience has a price to earnings ratio (PE ratio) of -3.54.

Satellos Bioscience Announces Results of Annual and Special Meeting of Shareholders

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a biotech company developing new small molecule therapeutic...

Satellos Bioscience to Participate in PPMD’s Annual Conference in Las Vegas

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a biotech company developing new small molecule therapeutic...

Satellos Announces Encouraging Functional Data from the 28-day Phase 1b Open-Label Trial of SAT-3247 in Adults with Duchenne Muscular Dystrophy

Phase 1b data shows treatment with SAT-3247 was safe and well-tolerated Pharmacokinetic (PK) profile of SAT-3247 translated as expected to...

Satellos Reports First Quarter 2025 Results and Highlights Recent Company Progress

- Completed enrollment in the Phase 1b trial in adult patients with Duchenne muscular dystrophy (DMD); data analysis and reporting expected in Q2...

Satellos to Present at the CureDuchenne FUTURES National Conference

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing...

Satellos to Present at Bloom Burton & Co. Healthcare Investor Conference

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing...

Satellos to Participate in Two April Investor Conferences

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a clinical-stage biotechnology company developing...

Satellos Reports 2024 Financial Results and Highlights Company Progress

– Completed enrollment and dosing in a Phase 1a clinical trial in 72 healthy volunteers to assess safety and pharmacokinetic (PK) properties of...

Satellos Presents Initial Data from the Phase 1 Trial of SAT-3247 at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

- Phase 1a data shows SAT-3247 was safe and well tolerated in 72 healthy volunteers after both single and repeated administration - Phase 1a...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.08	15.3846153846	0.52	0.6	0.52	54321	0.55417394	CS
4	-0.14	-18.9189189189	0.74	0.75	0.52	203110	0.59819335	CS
12	-0.15	-20	0.75	0.76	0.52	169636	0.64120873	CS
26	-0.29	-32.5842696629	0.89	0.94	0.52	166063	0.72645524	CS
52	0.01	1.69491525424	0.59	1.32	0.45	139485	0.73099626	CS
156	-0.02	-3.22580645161	0.62	1.32	0.38	119515	0.70615928	CS
260	-0.02	-3.22580645161	0.62	1.32	0.38	119515	0.70615928	CS

MSCL - Frequently Asked Questions (FAQ)

What is the current Satellos Bioscience share price?

The current share price of Satellos Bioscience is $ 0.60

How many Satellos Bioscience shares are in issue?

Satellos Bioscience has 165,820,000 shares in issue

What is the market cap of Satellos Bioscience?

The market capitalisation of Satellos Bioscience is CAD 96.18M

What is the 1 year trading range for Satellos Bioscience share price?

Satellos Bioscience has traded in the range of $ 0.45 to $ 1.32 during the past year

What is the PE ratio of Satellos Bioscience?

The price to earnings ratio of Satellos Bioscience is -3.54

What is the reporting currency for Satellos Bioscience?

Satellos Bioscience reports financial results in CAD

What is the latest annual profit for Satellos Bioscience?

The latest annual profit of Satellos Bioscience is CAD -28.1M

What is the registered address of Satellos Bioscience?

The registered address for Satellos Bioscience is 79 WELLINGTON STREET WEST, 33RD FLOOR, TORONTO, ONTARIO, M5K 1N2

What is the Satellos Bioscience website address?

The website address for Satellos Bioscience is www.satellos.com

Which industry sector does Satellos Bioscience operate in?

Satellos Bioscience operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
APLIAppili Therapeutics Inc	$ 0.015 (50.00%)	4.6k
BUBurcon NutraScience Corporation	$ 4.75 (25.66%)	79.77k
BSXBelo Sun Mining Corp	$ 0.30 (22.45%)	1.15M
PPRPrairie Provident Resources Inc	$ 0.03 (20.00%)	4k
MARIMarimaca Copper Corp	$ 7.11 (17.91%)	67.61k
TBLTaiga Building Products Ltd	$ 3.38 (-31.44%)	127.24k
OPTOptiva Inc	$ 1.42 (-14.46%)	2.63k
ELEFSilver Elephant Mining Corp	$ 0.22 (-10.20%)	173.89k
AEGAegis Brands Inc	$ 0.345 (-9.21%)	10.5k
DII.ADorel Industries Inc	$ 1.55 (-8.82%)	300
CNQCanadian Natural Resources Ltd	$ 43.25 (-1.97%)	19.62M
SUSuncor Energy Inc	$ 52.55 (-1.81%)	10.99M
CVECenovus Energy Inc	$ 18.80 (-1.67%)	10.68M
MFCManulife Financial Corporation	$ 43.27 (0.67%)	9.62M
BTEBaytex Energy Corp	$ 2.48 (-3.88%)	7.64M